Several Apache Corporation units have failed to block Santos from withdrawing admissions in a long-running fight over $83 million in tax credits related to Apache’s $2.1 billion sale of certain assets, with a judge finding Apache’s prejudice arguments were “significantly overstated”.
A judge has refused to strike out claims of serious harm in a defamation case by a pro-Israel activist against the owner of Sydney restaurant Cairo Takeaway, finding the activist did not need to plead to his prior reputation.
Law firm Gillis Delaney has defeated a bid for third-party costs by a warehouse management software company that was named in an intellectual property dispute, with a judge rejecting claims the firm was not authorised to act and acted unreasonably.
Meta has successfully opposed an Australian start-up’s ‘Reelstar’ trade mark, with a delegate finding it was too similar to the social media company’s mark for its short-form video brand Reel.
The tax commissioner has suffered a major loss in a dispute with Malaysian power company YTL Power over a $948 million capital gain from the sale of its stake in South Australia-based ElectraNet in 2022.
Meriton has won summary dismissal of a security concierge’s Fair Work claims, with a judge finding the case had no prospects of success.
An adjudicator’s decision awarding $10 million to a builder on Queensland developer Heran Group’s high-rise luxury apartment building in Main Beach lacked procedural fairness after he went outside the parties’ submissions, a judge has found.
A builder has lost an appeal arguing that a RW Capital unit was bound by an alleged contract to develop land in northern Sydney, said to be worth $25.75 million, after the trial judge found the claim was “doomed to fail”.
The lead plaintiffs in a lawsuit against Transport for New South Wales over the compulsory acquisition of land for the WestConnex road project have won their bid to toss a third suit brought by the funder which backed the case.
Suspecting infringement of patents for its Parkinson’s drug, Xadago, biopharmaceutical company Newron has won preliminary discovery of documents from generic drug maker Arrotex Pharmaceuticals.